Does AMPRENAVIR Cause Kaposi's sarcoma? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Kaposi's sarcoma have been filed in association with AMPRENAVIR. This represents 9.2% of all adverse event reports for AMPRENAVIR.
10
Reports of Kaposi's sarcoma with AMPRENAVIR
9.2%
of all AMPRENAVIR reports
0
Deaths
7
Hospitalizations
How Dangerous Is Kaposi's sarcoma From AMPRENAVIR?
Of the 10 reports, 7 (70.0%) required hospitalization.
Is Kaposi's sarcoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMPRENAVIR. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does AMPRENAVIR Cause?
Virologic failure (36)
Viral mutation identified (34)
Drug resistance (24)
Pathogen resistance (24)
Treatment failure (24)
Pancytopenia (13)
Drug ineffective (11)
Toxicity to various agents (11)
Dysuria (10)
Hiv infection (10)
What Other Drugs Cause Kaposi's sarcoma?
TACROLIMUS (755)
PREDNISONE (687)
MYCOPHENOLATE MOFETIL (624)
PREDNISOLONE (335)
METHYLPREDNISOLONE (318)
CYCLOSPORINE (219)
RITUXIMAB (200)
CYCLOPHOSPHAMIDE (191)
METHOTREXATE (182)
AZATHIOPRINE (177)
Which AMPRENAVIR Alternatives Have Lower Kaposi's sarcoma Risk?
AMPRENAVIR vs AMPYRA
AMPRENAVIR vs AMRUBICIN
AMPRENAVIR vs AMSACRINE
AMPRENAVIR vs ANAGRELIDE
AMPRENAVIR vs ANAKINRA